Back to Search
Start Over
Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2-5
- Source :
- Pediatric Nephrology. August, 2023, Vol. 38 Issue 8, p2763, 8 p.
- Publication Year :
- 2023
-
Abstract
- Background Dyslipidemia is a potentially modifiable risk factor in patients with chronic kidney disease (CKD). Information on the safety and efficacy of statins in pediatric CKD is limited. Methods Patients with CKD stage 2-5 and aged 5-18 years with low-density lipoprotein cholesterol (LDL-C) > 130 mg/dL and/or non-high-density lipoprotein cholesterol (non-HDL-C) > 145 mg/dL were enrolled from September 2019 to February 2021. All patients were administered atorvastatin 10 mg/day, which was escalated to 20 mg/day if LDL-C remained > 100 mg/dL and/or non-HDL-C > 120 mg/dL at 12 weeks. Proportion of patients achieving target lipid levels (LDL-C [less than or equal to] 100 mg/dL and non-HDL-C [less than or equal to] 120 mg/dL) and adverse events were assessed at 24 weeks. Results Of 31 patients enrolled, target lipid levels were achieved in 45.2% (95% CI 27.8-63.7%) at 24 weeks; 22 patients required dose escalation to 20 mg at 12 weeks. There was no difference in median lipid level reduction with 10 (n = 9) versus 20 mg/day (n = 22, P = 0.3). Higher baseline LDL-C (OR 1.06, 95% CI 1.00-1.11) and older age (OR 36.5, 95% CI 2.57-519.14) were independent predictors of failure to achieve target lipid levels with 10 mg/day atorvastatin. None had persistent rise in AST/ALT > 3 times upper normal limit (UNL) or CPK > 10 times UNL. No differences were noted in adverse events due to atorvastatin 10 or 20 mg/day. Conclusion Atorvastatin (10-20 mg/day) administered for 24 weeks was safe and effectively reduced LDL-C and non-HDL-C in children with CKD stages 2-5. Patients with higher baseline LDL-C required higher doses to achieve the target. Graphical abstract<br />Author(s): Punitha Lakxmi Ramesh [sup.1] , Priyanka Khandelwal [sup.1] , R. Lakshmy [sup.2] , Aditi Sinha [sup.1] , Arvind Bagga [sup.1] , Pankaj Hari [sup.1] Author Affiliations: (1) grid.413618.9, 0000 [...]
Details
- Language :
- English
- ISSN :
- 0931041X
- Volume :
- 38
- Issue :
- 8
- Database :
- Gale General OneFile
- Journal :
- Pediatric Nephrology
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.759337815
- Full Text :
- https://doi.org/10.1007/s00467-023-05887-0